Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'd like to see that too.
I've met the man in person. He's why I invest here. Market potential and technology here sure.
Guessing we should be in for a nice 2nd half of the year? Things are a little quiet now, must be hard at work getting this production ramped up and ready to market.
It's rare I have time to get on ihub but I figured I'd pop in today. Hope everyone is good here.
Happy to add another 10k shares this morning
Hey yall. Took a new job awhile back and haven't been on here since. Haven't had the time but I still own a ton of this as a long term investment. Been here 2 years so far. Sad to see it back so cheap.
Haven't seen any news in awhile, where are we at with expected news/updates on the product?
Been busy, but still here. Just checking in with everyone.
The trial results were excellent, onward we go! Slighly surprised not to see this higher but all this sideways consolidation is building a nice strong base. For about 3'ish months it was 30s/40s now we've been around 60s for a few months, no complaints. Whatever the next range is should probably be 90s-$1+.
Unfortunately have to head out on a day we get a nice pullback to buy some more but I threw in some bids around .56. Fingers crossed.
Yep - considering his resume, he surely knows 'all' the CEOs of healthcare companies and plenty of institutional investors on wall street. Terry is why I own the stock.
I believe they'll wait until AC5 is launched in EU and in the US. The value here will exponentially increase as more happens (product launch - sales, FDA clearance, etc). I presume we're a couple years away from a buyout. I'm confident one will happen, by a large medical device company. JNJ makes the most sense to me still. I also think $1B is too low. Sounds nice right now but in a couple years I think we'll be thinking of a bigger number.
They are dong perfect where they are, yes. Don't look at the negatives, look at the glass full. A solid 50%, imo, of institutions and retail brokers, (imo over 70%+) can purchase listed companies vs the small amount that can when it's an OTC. Shareholder base (also aka the mass amount of money that can buy it) will substantially increase. But like I've stated imo a split is no topic to be discussed right now, if ever. Millions of dollars is a drop of rain in a downpour... the money the real guys have, that can buy this once it's NSDQ, is massive. We'll get there.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124055190
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124074736
Institutions work both sides but here, imo, net long, and are the stable buyers that will drive it up to dollars, uplisting, and on. If I can't short an OTC stock I have no concerns about it. If it's done then I presume they are just controlling a pullback and consolidation and will buy it back 3x over and keep moving it up.
And, I've met Terry N. about a year and a half ago. I had 1 question for him. This was back about a year and a half ago when the stock was .20 and the MCAP was sub $20mil. It was: Who offered to buy you out and how much was the buyout offer? (I assumed someone offered, to be clear). The answer was a very big smile/smirk.
MCAP is around 100mil now? surely the offer (assuming his smile and answer of secrecy meant..) was several hundred million. Like I've said - assumptions are he wasn't at least a couple billion. IMO the MCAP will eventually be that, be it through stock appreciation or a buyout
I don't imagine they will need to but it's always a possibility and I'm sure Terry doesn't rule anything out. He used to manage the worlds 2nd largest healthcare fund at Putnam Investments and was a lead drug analyst for the FDA so when it comes to the markets and the sector, he knows everybody and all anyone could know. If it ever were to happen I'd be happy bc he won't do anything that would take the stock backwards. All things assumed, won't need to. If he did, I bet it'd be about a 3x split once the pps is well over $1, likely $2. We're a ways from even speculating about something like that. imo it'll go to several dollars naturally in time, and keep going. You are right in the sense more 'people' can own it once it's non-otc. I believe I posed something like that in one of my very previous posts.
haha I hear you on that!
I feel that once $1 breaks and holds, with a continued increase in the fundamental value (production, distribution, selling, then FDA, etc) I assume price will be driven substantially higher with the first goal of uplisting it onto the Nasdaq.
OTC greatly restricts the potential shareholder base because many brokerage firms/ and/or most advisors at those firms, aren't allowed by compliance to purchase OTC stocks like this. This goes for the institutional side as well. I believe the percentage of financial advisors in the US that are allowed to purchase OTC stocks is somewhere between 5 and 8%. And of that 5-8%, most won't dare put their career on the line to recommend something like this, or even look at it for more than 2 seconds. An uplisting I believe is high on the priority list once positive human trial results are hopefully announced.
Right on to still hold them all! I have a solid core position (which is nearly half of my total account value haha) and then I collect free shares. I probably make a buy/sell here once every 1-2 months when we get a big (relative) dip and then strong buying. My core position I have always planned to start selling a tenth of the shares at $2, another tenth at each dollar on up to $10 then hold a tenth for a big buyout if it hasn't happened already. And then like I said, add some free shares to my investment every month or two.
At the end of the day I don't have the will power to sell the shares because I know someone could offer to buy these guys out for $500million tomorrow and my belief is that it'd be turned down cause it's not at least a couple billion. That's where I see it going over the years. Which is at least 20x the current market value
It's been a little while since we've heard anything, and per what the last PR said, we should hear something soon. So, I assume Arch let's us know something in the next week or so in regards to the human trial. We'll see! My faith in Terry & Co has me excited that once we do hear something, it'll be good.
Avg daily vol is a couple million + shares I presume. imo a tenth of that all on the offer, in short order, will clear it back to the .70's.
Who do you think bought it all up from .50's to the .90's? The uptick in dollar volume + all the buying at the ask and massive bids that weren't showing true to size.. doubt that was retial people like us here on this board. Just wait until these small institutional buyers pick up the pace. Consider what may happen when bigger institutions get involved. They buy millions, tens or hundreds of millions, of dollars worth of stocks that trade multiple dollars+. A stock like this is a drop in the bucket. Consider also just how many of the shares here are held tightly, and buy who.
Attention Guys. *** I've been invested since April 2015. Now, over a year later, it's seen .20 to almost 1. My lowest buy was at .165. In a year or two I think it'll be worth several dollars at least.
Anyone who truly knows what this company is doing, their market, what they are setting up for (lot's of puzzle pieces and once you put them all together using logic, then you'll see), their CEO, etc, wouldn't think about selling all out until much later.
I don't think many on ihub (or 99% of retail people) have a clue of how strong the fundamentals are here and what's is setting up for years to come.
Anything can happen sure. But read all the news the past 2 years and do some serious DD and I bet you'll see what I do.
For all you traders here, do your thing. This thing is bigger than we can imagine.
My input, if you are a trader, is always hold onto free shares as an investment on the house.
I imagine good results on the human trials will send this over $1 and from there I can only assume we'll see distribution partner(s) that imo are in place will be announced, manufacturing will be ready to meet demand, sales teams ready, AKA everything for a full scale launch in Europe will be ready. Then the human trial results on this medical device to be given to the FDA for clearance then a full scale launch in the US.
Through my DD on the market for hemostatic devices leaves me with the assumption (my best guess) that Johnson & Johnson $JNJ may likely be a distribution partner for $ARTH. And/or buy ARTH out for a couple billion dollars. May sound out there to some. Who knows right?
All just my opinion. I know what I own and why.
Very nice pullback to buy more! I certainly did.
It's so nice to see this finally move!
I think by the end of the year this could very well be over $1.
Per PRs, final human trial results likely in the next couple of months then the CE mark application. It'd be nice to see distribution announcements and the product launch by end of year.
I love how they have more products in the pipe past this AC5 that have even more potential than the billion or two AC5 can generate. imo
Incredible action lately. Took some off the top here.
My core position I won't shake until probably a year or two out (at a higher price) but I can't be greedy with my non-core position. Gotta follow my own rules.
Long-term play here, one I do believe in a lot.
Have a great weekend all.
There are many people accumulating as large of positions as possible. I'm sure you saw the list of private investors quite awhile back. All limited to a set dollar amount because Terry knows what he's doing- keeping majority ownership so he can run the company as it should be until valuations reach 3-4 billion (market cap). My opinion.
I do agree. Lots more to come imo!
Definitely! Terry & Company know exactly what they're doing. Arth I do believe will be worth at least a few bucks in the coming years.
Clearly time to start the continued move higher! (I've been a long-term shareholder here for over a year, true investment).
Some data coming out should be followed by more good data, successful completion of human trials, the CE mark, and a product launch across Europe. I presume they likely already have everything in place such as distribution partner(s), etc.
Successful human trials = all data needed to clear a medical device through the FDA as quickly as possible.
Would like to see a continued move back into the 30s off of this and what's likely to come near term.
Everyone should own a lot of $ARTH
All my opinion.
Ya I think the plan was to start by end of year 2015 but all the regulatory organizations don't move as fast as Terry Norchi does (of course). Now that things are beginning to be rolling on the trial side ARTH is all set.
Doing the human trials where they are, for the CE mark, should give them the data required to get it approved quickly through the FDA (relative to doing the human trial in the U.S. first).
and yes 21money21, I thought we'd be over $1 by now too. Multiple dollars in a couple years.
I've watched every trade for the most part. I love it. Clearly there's 1 or 2 really big buyers and they came back again today buying it again. Clearly an indication that someone knows something. That or some fund found the gem that we did and needs all the shares they can scoop. Probably both.
Noticed this on the breakout boards. Checked it out. If you notice the press a few days back it states they did the reverse along with a proposal to uplist to the Nasdaq. Listing requirements require a certain PPS thus the r/s necessary. Going from OTC to Nasdaq is extremely advantageous for many reasons. Lots of big money cannot buy an OTC company but they can buy Nasdaq. Green today probably means something good.
I whole-heartedly agree with you. Best of luck to us in the years to come here.
Had this one a couple years back at .055, played out nicely. Still on radar but currently no position. The further it pulls back the more enticing it is. I wonder what a long term outlook is for the services that this company provides. As drilling and servicing technologies becomes better, efficiency in many areas is the result, including a reduction in water usage. I am not being negative. It was a random thought as I begun typing this post.
Very nice run this one has been on. Clearly someone is buying steadily. May do some DD here.
Excellent first quarter I agree. Thank you for posting the summary.
They can PR all they want in my opinion but if it's any fluff I don't want it. I want fillings, go current info status, and report anything when it needs to be reported.
Once my schedule winds down I'll just call the CEO if I can find his number. Also, since my schedule is so busy, I haven't had much of a chance to DD it... but then again, there's nothing much to DD since no filings or news other than a couple items out months ago.
If anyone has it or can find it for me let me know. I can handle that call.
Everything I wrote, factual wise, is sourceable. I didn't know I was to site my sources. Let's start with every piece of news in the past year and the past 3 annual reports, the fact sheet and investor presentation. Everything is documented. You have google too.
And I'm not trying to persuade anybody. It's not investment advice you're aware.
Aren't we all an anonymous writer?
If you aren't happy with PLSB why are you here? Come back in a year or two. There's money to made at .20 in my opinion. My post is me stating why I'm invested here. I've been researching this company for 4+ months now.
Pulse Beverage = Bargain Priced at .20
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=113514126
Investment idea for you watch list:
All are emerging growth.
PLSB
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=113514126
ARTH,VYCO,ESES,INO
Pulse Beverage (OTC: PLSB.QB) is an emerging growth beverage company that manufactures and distributes Natural Cabana® Lemonade, Limeade, and Natural Cabana™ Coconut Water. Pulse Beverage has also commenced distribution of its flagship product PULSE HEART AND BODY HEALTH brand of functional beverages, originally developed by Baxter Healthcare Corp., a subsidiary of Baxter International, Inc. (NYSE:BAX). At present, the beverage industry is trending towards niche beverages that contain functional ingredients that have shown to promote health, and away from the broad consumption of carbonated soda drinks. Due to declining growth in traditional soda sales, major beverage companies are seeking to participate in the growing functional beverage sector.
Distribution
Pulse Beverage spent the majority of 2012 through 2014 building its distribution system in order to secure listings with regional and national grocery and convenience chain stores such as Albertsons/Safeway, Walmart, Kroger/Fred Meyer/Ralphs, Kmart, Circle K, Walgreens, 7-Eleven, Whole Foods, H-E-B, Hy-Vee Supermarket, Save Mart Supermarkets, Hannaford, Food City, Raley's Supermarkets, Price Chopper Supermarkets, WinCo Foods, and Gelson's Super-market.
Distribution Summed Up:
Pulse introduced Natural Cabana® Lemonade in 2012 and in just 3 years went from nothing to a multi-national distribution system with more than 150 distributors in 49 States, Canada, Mexico, Panama, Bermuda and Ireland.
As of 12/31/2014 Pulse secured approximately 20,000 Store Listings for their Lemonades/Limeades and about 5000 Store Listings for their Coconut Waters.
The Pulse team has set more than 300 Walmart stores to date; Pulse is in the process of setting 4,000 retail stores for April, May and June: more than 3,500 stores are being set for Natural Cabana® Lemonades/Limeades, 500 for Coconut Waters, and 300 for PULSE® Heart & Body Health functional beverages.
Pulse is currently negotiating with regional and national chain stores that have the potential of 13,000 additional stores selling one or all of its brands: more than 8,000 for Lemonade/Limeade, more than 7,000 for Coconut Water, and more than 5,500 for PULSE®;
They have secured nearly 3,000 Store Listings for initial distribution in Mexico. The distribution is just now getting underway.
They are already in Canada. They just recently signed an agreement with Unique Foods, a major Canadian national distributor. Recent news states an added 500 7-11 stores in Canada, all corporately owned.
***Do the math. 1+1 = 2. Pulse just launched Limeade in January, 2014, and Coconut Waters in March, 2014. That said, Pulse has spent 3.5 years setting everything up, on little to no cash too, and now it is time. Nearly doubling distribution this year, financing secured, expansion in Mexico, additional expansion internationally, and Walmart looks to be huge, and the launch of Pulse Heart & Body Health NOW this May (originally developed by Baxter Healthcare).
This looks to be their breakout year!
International Distribution Breakthroughs
Mexico is HUGE for Pulse:
The Pulse Beverage Corporation has established a Mexican wholly owned subsidiary to distribute Natural Cabana Lemonades, Limeades and Coconut Water. Mexico is a massive beverage market and has been reported as the largest consumers of soft drinks per capita in the world. Pulse’s Mexico business will be headed by Carlos Villarreal and his team. Mr. Villarreal was responsible for the Mexican introduction and distribution of Monster Energy and he built the brand from 25,000 cases per annum to over 2.5 million cases per annum in just over five years. Pulse has signed a distribution agreement with a major distribution firm in Mexico to distribute its lemonades, limeades and coconut water products. This major Mexican distributor has been in business for over 60 years and has 1300 employees, 400 delivery trucks, and more than 30 distribution centers with delivery routes covering all of Mexico. The Company (Pulse) is presently also negotiating an import distribution agreement with a major import company in China.
Expansion into Canada:
We secured a distribution agreement with Unique Foods (Canada) Inc. (“Unique Foods”) in September, 2014 to distribute Natural Cabana® Coconut Water throughout Canada. Unique Foods is headquartered in Montreal, Canada with an established presence in Atlantic and Western Canada, Ontario and Quebec through coordinators and multiple independent regional distributors. Unique Foods is a leading importer of premium beverage brands such as: Stewart’s Old Fashioned Sodas, Cascade Ice™, Hype Energy™, AQUAhydrate™ and ACTIVATE® Vitamin Drinks.
What I think:
Cases Sold in 2014 = 334,000
Q1 ’14 about 55,000
Q2 ’14 about 126,000
Q3 ’14 about 100,000
Q4 ’14 about 53,000
There are many reasons for investing in Pulse. Growth is one of them. Every quarter for 2015 that Pulse increase the amount of cases sold quarter over quarter for same period last year by 10%+ I will buy more. I will buy more because of the growth. Example; When we get Q1 ’15 #’s, if Pulse sells 10% more than 55k cases meaning they sell at least 60k, I’ll buy more because the growth is there. I encourage other investors to do the same.
I also think that with their execution through distribution this is the year they turn cash flow positive. I think that may be shown in the Q3 ’15 numbers. That is my guess. Serious buying going into these next 2 quarters is what I’ll be doing. Some of my buddies will be too.
Something to sink your teeth into:
The Pulse team are the same guys that started Clearly Canadian in the 1980’s. They took it from a start up to $178 Million in sales. I think that was over a 10 year period. However, in just 3 years, the brand went from start-up to 4.8 million cases.. in just 3 years!
The stock? Oh yeah, that went from .67 cents to over $28 dollars. I believe the stock was in the low teens when PepsiCo offered to buy them out at $19/share and Clearly Canadian turned them down!! The stock continued to run to $28.
I’m not saying Pulse will do that. I’m making a point these guys have done it before. Where do I think Pulse will be? I believe there’s potential to see multiple dollars in the next 12-18 months.
CEO Bob Yates also launched his own brand, Kwencher, and grew it to a 1.7 million case brand in less than 2 years through distribution Solely to Walmart.
Management has plenty more experience than just what I stated above. My point is these guys have done it before, and are doing it again. The stock in my opinion is undervalued and the market has it all wrong right now. I think a reason may be because the stock got ahead of itself in the past.. people were thinking way ahead of themselves on expectations. Now the market is more cautious and is wait and see mode. I’m not on that boat. Everything is aligned, set up, and it’s go time. Happy Investing.
P.S.
Coca Cola met with the Pulse team twice so far. When they met they said show us you have a viable product that sells well in the market. Coke gave Pulse a 1 million case proof on concept benchmark to prove that then talk about a buyout. I think the possibility of Coke buying out Pulse is real. I also think another beverage company may buy them out at some point.
I will get another post up like this one talking about market comparables.
I have a question for current shareholders;
I started looking a little bit at this company through this article I found http://marijuanastocks.com/top-5-marijuana-stocks-watch-2015/
I looked at their share structure. They have 600Mil shares A/S, and their O/S is now maxed. This implies to me that either; They will increase their A/S and continue to raise capital like mad men through the market, or do an R/S
I added this to my watch list but I can't buy something with a s/s like this. I feel an R/S coming
My question. Does anyone have the same thoughts?
Thank you very much I'll check into it for sure.
There is so much more to ARTH than meets the eye. Full disclosure I do not own and have never bought it (yet).
Their product that stops bleeding was an accidental find while doing R&D for what their main goal is. Consider the possibilities of being bought out by a big bio tech/pharma company for several hundred million at a minimum based just off the accidental product.. tip of their iceburg if you will.
I'm assuming you know the CEO's full history. Considering what he used to do (including running the worlds 2nd largest bio-tech fund for Putnam Investments ($4billion bio-tech fund)), why would he give up sooo many years of his life devoting it to a company this size.
PLSB I'll get some DD too you in a few weeks (earlier if possible - I know the company in and out more or less). I'm just slammed busy for another few weeks. What's easy to say now is that anything sub .20 is great, sell half mid/low .30's and stack free shares. It's not going lower. It's bottomed here for months and held and I've watched it trade for months. It appears nowhere to go but up.
ENCR I'll add it to my watch list in the morning and start some DD there.
Looking 1-2-3 years out if we're going that route, VYCO, ESES, ADMP, and quite possibly ONCS (a spin-off from INO) all have my vote. ESES won't go lower than where it is imo. VYCO anything sub 1.60 appears a good scoop up. ADMP mid 3's if possible. PLSB and ARTH anything sub .20.
giving you a member mark. cheers
Long-term this'll be dollars. I'm trying to fill it at .17 now. I own 0 shares. I'm also a cheapie with long term patience. .17 is good with me for dollars in 1-2 years.
Pulse Beverage Corporation same exact siltation. Different companies, sectors, reasons for going to multiple dollars as investments but I feel it'll happen with both these companies. Don't know why PM me.
Cheers fellow investors,
GM
Executing on what they stated they'd do. We're looking at a shit ton more stores this year. I'm so happy to see and additional 300 stores roughly, by years end we can likely see tens of thousands added imo